script.reportAU
Metabolic

Amino acid formula with vitamins and minerals without valine, leucine, isoleucine, supplemented with arachidonic acid and docosahexaenoic acid

Brand: MSUD explore5

PBAC's latest decision on Amino acid formula with vitamins and minerals without valine, leucine, isoleucine, supplemented with arachidonic acid and docosahexaenoic acid: Recommended (2023). Considered for Dietary management of maple syrup urine disease (MSUD) in infants and young children from 6 months to 5 years of age.

PBAC outcome
Recommended
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2023
Submissions
1
2023 → 2023

Eligible population

Infants and young children aged 6 months to 5 years with maple syrup urine disease (MSUD) requiring dietary management.

Therapy area
Metabolic
Line of therapy
Any
Evidence base
Cost-minimisation
Primary endpoint
Cost-minimisation
Comparator
MSUD gel (primary comparator); MSUD cooler10 and MSUD Anamix Junior/MSUD Anamix Junior LQ (secondary comparators)
Economic model
Cost-minimisation
Eligible patients/year
1
ICER note
Cost-minimisation analysis; no ICER calculated. MSUD explore5 was cost-minimised to comparators at equivalent price per gram of protein equivalent ($1.33 per gram PE).

Similar precedents

Open on full dashboard →